Viewing StudyNCT00006104



Ignite Creation Date: 2024-05-05 @ 11:19 AM
Last Modification Date: 2024-10-26 @ 9:05 AM
Study NCT ID: NCT00006104
Status: COMPLETED
Last Update Posted: 2012-08-14
First Post: 2000-08-03

Brief Title: Trastuzumab Plus Docetaxel in Treating Women With Recurrent or Metastatic Breast Cancer
Sponsor: Vanderbilt-Ingram Cancer Center
Organization: Vanderbilt-Ingram Cancer Center

Conditions & Keywords Data

Conditions:
Name
Breast Cancer
Keywords:
Name View
recurrent breast cancer View
stage IV breast cancer View